Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer

OBJECTIVES: Immune checkpoint inhibitor immunotherapy (IO) is revolutionizing cancer care but can lead to significant toxicity. This study seeks to describe potential risk factors for immune-related adverse events (irAEs) specifically among older adults. MATERIALS AND METHODS: This was a retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Johns, Andrew C, Yang, Mike, Wei, Lai, Grogan, Madison, Spakowicz, Daniel, Patel, Sandipkumar H, Li, Mingjia, Husain, Marium, Kendra, Kari L, Otterson, Gregory A, Rosko, Ashley E, Andersen, Barbara L, Carbone, David P, Owen, Dwight H, Presley, Carolyn J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Geriatric Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400153/
https://www.ncbi.nlm.nih.gov/pubmed/37085156
http://dx.doi.org/10.1093/oncolo/oyad097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400153/
https://www.ncbi.nlm.nih.gov/pubmed/37085156
http://dx.doi.org/10.1093/oncolo/oyad097

Ejemplares similares